Go Back

Content Compliance, Simplified

Vodori is on a mission to transform lives by bringing regulated products to market faster. We help life science teams stay compliant and improve the material review process with intuitive, tailored software and peerless customer support. Subscribe for best practices and insights on the material review process, regulatory compliance, and team collaboration.

Content Compliance, Simplified

Software & Technology

Revolutionizing Pharmaceutical Ethics: UK’s ABPI Code of Practice Ushers in a New Era of Self-Regulation

March 20, 2024
Code Clarity
Dr. Joe DiCapite
Rina Newton
UK ABPI Code of Practice
+more
MarketScale

 

In a dynamic era where the intersection of healthcare, regulation, and technology demands constant vigilance, the UK’s ABPI Code of Practice stands as a testament to the pharmaceutical industry’s commitment to self-regulation. Amidst a backdrop of historical challenges and technological advancements, this code serves as the rulebook guiding the ethical conduct of pharma companies within the UK. With the pharmaceutical landscape evolving at an unprecedented pace, the impending updates to the ABPI Code for 2024 have sparked a vital discussion on the balance between innovation, compliance, and patient safety.

What modifications can stakeholders expect in the 2024 iteration of the ABPI Code of Practice? How will these changes influence the operational and ethical frameworks of pharma companies in the UK?

Welcome to “Amend & Progress,” a podcast brought to you by Vodori, dedicated to exploring the intricacies of promotional material review processes. Today, our host, Annalise Ludtke, delves into the anticipated updates to the UK’s ABPI Code of Practice alongside two distinguished guests: Dr. Joe DiCapite, Director of Strategy for the UK and Europe at Vidori, and Rina Newton, co-founder of Code Clarity and a leading expert in code compliance.

In this enlightening conversation, they explore:

  • The essence and importance of the ABPI Code of Practice and its role in self-regulation.
  • The anticipated changes in the 2024 update, including the streamlining of the signatory process and the introduction of validation requirements for signatories.
  • The innovative use of QR codes in promotional materials to enhance access to prescribing information.

Dr. Joe DiCapite brings a wealth of experience in strategic planning and regulatory compliance, having extensively worked on navigating the complexities of the ABPI Code. Rina Newton, renowned for her expertise in code compliance, has played a pivotal role in shaping the dialogue around ethical practices within the pharmaceutical industry in the UK.

Recent Episodes

SafeHaven
View episode

Ripple of Change: SafeHaven with Melina Davis and Dr Ally Jaffee

At a time when the mental health of healthcare professionals is under intense scrutiny, the SafeHaven program emerges as a beacon of hope. With rising burnout rates among medical staff, the necessity for confidential support systems is more evident than ever. What are the barriers preventing healthcare professionals from seeking the help they need?…

employee health
View episode

Achieving Organizational Excellence is Possible by Promoting Employee Health and Mindfulness

Employee health and well-being have become a critical focus for organizations in today’s rapidly evolving workplace. With the increasing prevalence of chronic stress and burnout, especially in healthcare, the stakes are higher than ever. Research shows that  80% of chronic diseases are preventable, emphasizing the need for effective workplace health strategies. How can leaders create…

MSK populations
View episode

The Dynamic Duo Helping MSK Populations!

Discover how a dynamic duo partnered with innovative, value-based strategies to revolutionize care for MSK populations. As musculoskeletal (MSK) conditions like osteoarthritis and back pain continue to rise, innovative partnerships are vital to delivering effective, value-based care. Recent studies show that MSK conditions are among the leading contributors to disability in the U.S., highlighting…